• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白乙酰化在调节内皮功能中的作用

The Role of Histone Protein Acetylation in Regulating Endothelial Function.

作者信息

Fang Zhi, Wang Xiang, Sun Xiaoran, Hu Wenquan, Miao Qing R

机构信息

Department of Foundations of Medicine, New York University Long Island School of Medicine, Mineola, NY, United States.

Department of Neurology, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Front Cell Dev Biol. 2021 Apr 29;9:672447. doi: 10.3389/fcell.2021.672447. eCollection 2021.

DOI:10.3389/fcell.2021.672447
PMID:33996829
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8113824/
Abstract

Endothelial cell (EC), consisting of the innermost cellular layer of all types of vessels, is not only a barrier composer but also performing multiple functions in physiological processes. It actively controls the vascular tone and the extravasation of water, solutes, and macromolecules; modulates circulating immune cells as well as platelet and leukocyte recruitment/adhesion and activation. In addition, EC also tightly keeps coagulation/fibrinolysis balance and plays a major role in angiogenesis. Therefore, endothelial dysfunction contributes to the pathogenesis of many diseases. Growing pieces of evidence suggest that histone protein acetylation, an epigenetic mark, is altered in ECs under different conditions, and the acetylation status change at different lysine sites on histone protein plays a key role in endothelial dysfunction and involved in hyperglycemia, hypertension, inflammatory disease, cancer and so on. In this review, we highlight the importance of histone acetylation in regulating endothelial functions and discuss the roles of histone acetylation across the transcriptional unit of protein-coding genes in ECs under different disease-related pathophysiological processes. Since histone acetylation changes are conserved and reversible, the knowledge of histone acetylation in endothelial function regulation could provide insights to develop epigenetic interventions in preventing or treating endothelial dysfunction-related diseases.

摘要

内皮细胞(EC)构成了所有类型血管的最内层细胞层,它不仅是一种屏障组成部分,还在生理过程中发挥多种功能。它积极控制血管张力以及水、溶质和大分子的外渗;调节循环免疫细胞以及血小板和白细胞的募集/黏附与激活。此外,内皮细胞还紧密维持凝血/纤维蛋白溶解平衡,并在血管生成中起主要作用。因此,内皮功能障碍是许多疾病发病机制的一个因素。越来越多的证据表明,组蛋白乙酰化作为一种表观遗传标记,在不同条件下的内皮细胞中会发生改变,并且组蛋白上不同赖氨酸位点的乙酰化状态变化在内皮功能障碍中起关键作用,涉及高血糖、高血压、炎症性疾病、癌症等。在本综述中,我们强调组蛋白乙酰化在调节内皮功能中的重要性,并讨论在不同疾病相关病理生理过程下,组蛋白乙酰化在编码内皮细胞蛋白质的基因转录单元中的作用。由于组蛋白乙酰化变化具有保守性且可逆,关于组蛋白乙酰化在内皮功能调节方面的知识可为开发预防或治疗内皮功能障碍相关疾病的表观遗传干预措施提供思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e853/8113824/fa4a5867a5ce/fcell-09-672447-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e853/8113824/e14e1694e1ad/fcell-09-672447-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e853/8113824/750ba2bc2c06/fcell-09-672447-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e853/8113824/db426d64554c/fcell-09-672447-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e853/8113824/fa4a5867a5ce/fcell-09-672447-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e853/8113824/e14e1694e1ad/fcell-09-672447-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e853/8113824/750ba2bc2c06/fcell-09-672447-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e853/8113824/db426d64554c/fcell-09-672447-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e853/8113824/fa4a5867a5ce/fcell-09-672447-g004.jpg

相似文献

1
The Role of Histone Protein Acetylation in Regulating Endothelial Function.组蛋白乙酰化在调节内皮功能中的作用
Front Cell Dev Biol. 2021 Apr 29;9:672447. doi: 10.3389/fcell.2021.672447. eCollection 2021.
2
Histone acetyltransferase 7 (KAT7)-dependent intragenic histone acetylation regulates endothelial cell gene regulation.组蛋白乙酰转移酶 7(KAT7)依赖性基因内组蛋白乙酰化调节内皮细胞基因调控。
J Biol Chem. 2018 Mar 23;293(12):4381-4402. doi: 10.1074/jbc.RA117.001383. Epub 2018 Feb 6.
3
Normal shear stress and vascular smooth muscle cells modulate migration of endothelial cells through histone deacetylase 6 activation and tubulin acetylation.正常切应力和血管平滑肌细胞通过组蛋白去乙酰化酶 6 激活和微管蛋白乙酰化调节内皮细胞的迁移。
Ann Biomed Eng. 2010 Mar;38(3):729-37. doi: 10.1007/s10439-009-9896-6.
4
The transcription factor Erg regulates expression of histone deacetylase 6 and multiple pathways involved in endothelial cell migration and angiogenesis.转录因子 Erg 调节组蛋白去乙酰化酶 6 的表达以及涉及内皮细胞迁移和血管生成的多个途径。
Blood. 2012 Jan 19;119(3):894-903. doi: 10.1182/blood-2011-04-350025. Epub 2011 Nov 23.
5
Histone acetylation regulates the cell-specific and interferon-γ-inducible expression of extracellular superoxide dismutase in human pulmonary arteries.组蛋白乙酰化调节人肺动脉细胞特异性和干扰素-γ诱导的细胞外超氧化物歧化酶的表达。
Am J Respir Cell Mol Biol. 2011 Nov;45(5):953-61. doi: 10.1165/rcmb.2011-0012OC. Epub 2011 Apr 14.
6
Endothelial SIRT6 Is Vital to Prevent Hypertension and Associated Cardiorenal Injury Through Targeting Nkx3.2-GATA5 Signaling.内皮 SIRT6 对于通过靶向 Nkx3.2-GATA5 信号预防高血压和相关的心肾损伤至关重要。
Circ Res. 2019 May 10;124(10):1448-1461. doi: 10.1161/CIRCRESAHA.118.314032.
7
Histone acetyltransferase GCN5-mediated lysine acetylation modulates salt stress aadaption of Trichoderma.组蛋白乙酰转移酶 GCN5 介导的赖氨酸乙酰化修饰调节木霉的耐盐适应。
Appl Microbiol Biotechnol. 2022 Apr;106(8):3033-3049. doi: 10.1007/s00253-022-11897-z. Epub 2022 Apr 4.
8
Deletion of inhibits neointima formation by enhancing KAT2A/GCN5-mediated acetylation of TUBA/α-tubulin .缺失可通过增强 KAT2A/GCN5 介导的 TUBA/α-微管蛋白的乙酰化来抑制新内膜形成。
Autophagy. 2021 Dec;17(12):4305-4322. doi: 10.1080/15548627.2021.1911018. Epub 2021 May 14.
9
Histone Acetylation Modifiers in the Pathogenesis of Alzheimer's Disease.组蛋白乙酰化修饰因子在阿尔茨海默病发病机制中的作用
Front Cell Neurosci. 2015 Jun 16;9:226. doi: 10.3389/fncel.2015.00226. eCollection 2015.
10
Vascular Endothelial Cell Biology: An Update.血管内皮细胞生物学:最新进展。
Int J Mol Sci. 2019 Sep 7;20(18):4411. doi: 10.3390/ijms20184411.

引用本文的文献

1
Nuclear receptors in metabolic, inflammatory, and oncologic diseases: mechanisms, therapeutic advances, and future directions.代谢、炎症和肿瘤疾病中的核受体:作用机制、治疗进展及未来方向
Eur J Med Res. 2025 Sep 9;30(1):843. doi: 10.1186/s40001-025-03073-6.
2
Hbo1 and Msl complexes preserve differential compaction and H3K27me3 marking of active and inactive X chromosomes during mitosis.Hbo1和Msl复合物在有丝分裂期间维持活性和非活性X染色体的差异压缩及H3K27me3标记。
Nat Cell Biol. 2025 Sep 8. doi: 10.1038/s41556-025-01748-0.
3
Histone Modifications as Individual-Specific Epigenetic Regulators: Opportunities for Forensic Genetics and Postmortem Analysis.

本文引用的文献

1
The key roles of the lysine acetyltransferases KAT6A and KAT6B in physiology and pathology.赖氨酸乙酰转移酶 KAT6A 和 KAT6B 在生理和病理中的关键作用。
Drug Resist Updat. 2020 Dec;53:100729. doi: 10.1016/j.drup.2020.100729. Epub 2020 Oct 7.
2
Current development of CBP/p300 inhibitors in the last decade.过去十年中 CBP/p300 抑制剂的最新发展。
Eur J Med Chem. 2021 Jan 1;209:112861. doi: 10.1016/j.ejmech.2020.112861. Epub 2020 Oct 1.
3
Histone Acetyltransferase p300 Inhibitor Improves Coronary Flow Reserve in SIRT3 (Sirtuin 3) Knockout Mice.
组蛋白修饰作为个体特异性表观遗传调节因子:法医遗传学和死后分析的机遇
Genes (Basel). 2025 Aug 7;16(8):940. doi: 10.3390/genes16080940.
4
Temporal and spatial distribution of histone acetylation in mouse molar development.小鼠磨牙发育过程中组蛋白乙酰化的时空分布
PeerJ. 2025 Mar 31;13:e19215. doi: 10.7717/peerj.19215. eCollection 2025.
5
Histone acetylation modulators in breast cancer.乳腺癌中的组蛋白乙酰化调节剂
Breast Cancer Res. 2025 Mar 31;27(1):49. doi: 10.1186/s13058-025-02006-9.
6
Pan-cancer analysis of the transcriptional expression of histone acetylation enzymes in solid tumors defines a new classification scheme for gliomas.实体瘤中组蛋白乙酰化酶转录表达的泛癌分析为神经胶质瘤定义了一种新的分类方案。
Front Immunol. 2025 Jan 21;15:1523034. doi: 10.3389/fimmu.2024.1523034. eCollection 2024.
7
Epigenetic mechanisms mediate cytochrome P450 1A1 expression and lung endothelial injury caused by MRSA in vitro and in vivo.表观遗传机制介导耐甲氧西林金黄色葡萄球菌在体外和体内引起的细胞色素 P4501A1 表达和肺血管内皮损伤。
FASEB J. 2024 Nov 30;38(22):e70205. doi: 10.1096/fj.202401812R.
8
Research progress and applications of epigenetic biomarkers in cancer.表观遗传生物标志物在癌症中的研究进展与应用
Front Pharmacol. 2024 Apr 12;15:1308309. doi: 10.3389/fphar.2024.1308309. eCollection 2024.
9
Epigenetic Alterations in Alzheimer's Disease: Impact on Insulin Signaling and Advanced Drug Delivery Systems.阿尔茨海默病中的表观遗传改变:对胰岛素信号传导和先进药物递送系统的影响。
Biology (Basel). 2024 Feb 28;13(3):157. doi: 10.3390/biology13030157.
10
Exploring epigenetic strategies for the treatment of osteoporosis.探索用于治疗骨质疏松症的表观遗传策略。
Mol Biol Rep. 2024 Mar 8;51(1):398. doi: 10.1007/s11033-024-09353-4.
组蛋白乙酰转移酶 p300 抑制剂改善 SIRT3(沉默调节蛋白 3)敲除小鼠的冠状动脉血流储备。
J Am Heart Assoc. 2020 Sep 15;9(18):e017176. doi: 10.1161/JAHA.120.017176. Epub 2020 Aug 31.
4
HDAC11: a rising star in epigenetics.HDAC11:表观遗传学的后起之秀。
Biomed Pharmacother. 2020 Nov;131:110607. doi: 10.1016/j.biopha.2020.110607. Epub 2020 Aug 22.
5
GCN5 acetyltransferase in cellular energetic and metabolic processes.GCN5 乙酰转移酶在细胞能量和代谢过程中的作用。
Biochim Biophys Acta Gene Regul Mech. 2021 Feb;1864(2):194626. doi: 10.1016/j.bbagrm.2020.194626. Epub 2020 Aug 19.
6
What do the structures of GCN5-containing complexes teach us about their function?这些包含 GCN5 的复合物的结构能告诉我们它们的功能是什么?
Biochim Biophys Acta Gene Regul Mech. 2021 Feb;1864(2):194614. doi: 10.1016/j.bbagrm.2020.194614. Epub 2020 Jul 31.
7
Non-histone protein acetylation by the evolutionarily conserved GCN5 and PCAF acetyltransferases.由进化上保守的 GCN5 和 PCAF 乙酰转移酶对非组蛋白蛋白进行乙酰化。
Biochim Biophys Acta Gene Regul Mech. 2021 Feb;1864(2):194608. doi: 10.1016/j.bbagrm.2020.194608. Epub 2020 Jul 22.
8
Epigallocatechin-3-gallate (EGCG) Alters Histone Acetylation and Methylation and Impacts Chromatin Architecture Profile in Human Endothelial Cells.表没食子儿茶素没食子酸酯 (EGCG) 改变组蛋白乙酰化和甲基化并影响人内皮细胞的染色质构象谱。
Molecules. 2020 May 16;25(10):2326. doi: 10.3390/molecules25102326.
9
Endothelial ZEB1 promotes angiogenesis-dependent bone formation and reverses osteoporosis.内皮细胞 ZEB1 促进血管生成依赖性骨形成并逆转骨质疏松症。
Nat Commun. 2020 Jan 23;11(1):460. doi: 10.1038/s41467-019-14076-3.
10
A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer.帕博利珠单抗和伏立诺他治疗复发性转移性头颈部鳞状细胞癌和唾液腺癌的 II 期临床试验。
Clin Cancer Res. 2020 Feb 15;26(4):837-845. doi: 10.1158/1078-0432.CCR-19-2214. Epub 2019 Dec 3.